actinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)

N/A

报告时间: 2025/01/26 18:43:30

基本信息

药物名称actinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)

药物别称actinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)high energy alpha emitting radioisotopes (NorthStar Medical Technologies)Ac-225/Bi-213 radioisotopes (NorthStar Medical Technologies)targeted alpha-particle therapy (NorthStar Medical Technologies)

药物类型生物药放射性产品

作用机制更新中

靶点更新中

治疗领域 / 适应症动脉粥样硬化急性髓细胞样白血病HIV感染

全球批准适应症N/A

中国批准适应症N/A

首批国家/区域N/A

首批日期N/A

国家/区域美国

是否复方否

全球最高研发状态临床前

中国最高研发状态N/A

原研公司NorthStar Medical Technologies LLC

注册分类N/A

研发信息

活跃公司NorthStar Medical Technologies LLC

非活跃公司N/A

活跃适应症动脉粥样硬化急性髓细胞样白血病HIV感染

非活跃适应症N/A

其他信息

ATC代码N/A